559 related articles for article (PubMed ID: 29406782)
1. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
Maekawa R; Ogata H; Murase M; Harada N; Suzuki K; Joo E; Sankoda A; Iida A; Izumoto T; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Arima H; Hayashi Y; Seino Y
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E572-E583. PubMed ID: 29406782
[TBL] [Abstract][Full Text] [Related]
2. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
[TBL] [Abstract][Full Text] [Related]
3. Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
Murata Y; Harada N; Yamane S; Iwasaki K; Ikeguchi E; Kanemaru Y; Harada T; Sankoda A; Shimazu-Kuwahara S; Joo E; Poudyal H; Inagaki N
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E53-E64. PubMed ID: 30990747
[TBL] [Abstract][Full Text] [Related]
4. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
Nasteska D; Harada N; Suzuki K; Yamane S; Hamasaki A; Joo E; Iwasaki K; Shibue K; Harada T; Inagaki N
Diabetes; 2014 Jul; 63(7):2332-43. PubMed ID: 24584548
[TBL] [Abstract][Full Text] [Related]
5. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
Moffett RC; Vasu S; Flatt PR
Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
[TBL] [Abstract][Full Text] [Related]
7. Absence of GIP secretion alleviates age-related obesity and insulin resistance.
Kanemaru Y; Harada N; Shimazu-Kuwahara S; Yamane S; Ikeguchi E; Murata Y; Kiyobayashi S; Hatoko T; Inagaki N
J Endocrinol; 2020 Apr; 245(1):13-20. PubMed ID: 31977316
[TBL] [Abstract][Full Text] [Related]
8. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
[TBL] [Abstract][Full Text] [Related]
9. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.
Hwang JS; Park JW; Nam MS; Cho H; Han IO
Metabolism; 2015 Mar; 64(3):368-79. PubMed ID: 25516476
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
Yamane S; Harada N; Inagaki N
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):20-6. PubMed ID: 27186351
[TBL] [Abstract][Full Text] [Related]
11. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
[TBL] [Abstract][Full Text] [Related]
12. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
13. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.
Porter DW; Irwin N; Flatt PR; Hölscher C; Gault VA
Eur J Pharmacol; 2011 Jan; 650(2-3):688-93. PubMed ID: 21050845
[TBL] [Abstract][Full Text] [Related]
14. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
Irwin N; McClean PL; Hunter K; Flatt PR
Diabetes Obes Metab; 2009 Jun; 11(6):603-10. PubMed ID: 19515180
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice.
Boer GA; Hunt JE; Gabe MBN; Windeløv JA; Sparre-Ulrich AH; Hartmann B; Holst JJ; Rosenkilde MM
Br J Pharmacol; 2022 Sep; 179(18):4486-4499. PubMed ID: 35710141
[TBL] [Abstract][Full Text] [Related]
17. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.
Althage MC; Ford EL; Wang S; Tso P; Polonsky KS; Wice BM
J Biol Chem; 2008 Jun; 283(26):18365-76. PubMed ID: 18420580
[TBL] [Abstract][Full Text] [Related]
18. Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice.
McShane LM; Irwin N; O'Flynn D; Franklin ZJ; Hewage CM; O'Harte FP
J Endocrinol; 2016 Jun; 229(3):319-30. PubMed ID: 27098830
[TBL] [Abstract][Full Text] [Related]
19. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
Pathak V; Gault VA; Flatt PR; Irwin N
Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
